Home Tags ADC manufacturing

Tag: ADC manufacturing

Featured Image: Pellicon® Capsule. Courtesy: © 2019 MilliporeSigma. Used with permission.

Pellicon® Capsules for Ultrafiltration/Diafiltration in the Antibody Drug Conjugate Manufacturing Process

Tangential flow filtration (TFF) is essential in the manufacturing of antibody drug conjugates (ADCs). Ultrafiltration (UF) is used to concentrate the protein product and...

Investing for the Future: Unlocking Advanced ADC Manufacturing Innovation

UPDATE: This event has been postponed until Fall 2019. Investment in ADCs (antibody-drug conjugates) has surged due to some very compelling market trends that include: ...

ADC Biotechnology Secures UK £1.14 million Investment

ADC Biotechnology has successfully secured UK £1.14 million in funding from, Downing LLP, a London-based investment management firm. The company, founded in 2010, is developing...

Ajinomoto Althea Expected to Open New Manufacturing Facility for Antibody-drug Conjugate...

Biopharmaceutical contract development and manufacturing services company, Ajinomoto Althea confirmed that announced it will soon open a GMP production suite in its newly constructed...

Lonza – Celebrating 10 Years as ADC Manufacturing Pioneer

By leveraging the company's experience in biopharmaceuticals and small molecule drug process development and scale-up, Lonza has been successful in manufacturing antibody-drug conjugates, a...

Contract Manufacturing of Antibody-drug Conjugates – A Growing Market

The demand for manufacturing capacity of antibody-drug conjugates (ADCs), which includes a highly potent cytotoxic drug linked to a monoclonal antibody and have shown to...

Strategic Collaboration Between CMC Biologics and IDT Biologika to Manufacture Antibody...

Denmark-based CMC Biologics, a company involved in the clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika, a privately-held...

Q&A – an Interview with Lonza’s Laurent Ducry

Antibody-drug Conjugates or ADCs are among the most exciting drug developments of the last decade. The combination of potent, small molecule drugs with the...

CPhI Worldwide 2015, Antibody-drug Conjugates and Market Progression

Ahead of CPhI Worldwide 2015, CPhI expert panelist, Vivek Sharma, CEO of Pharma Solutions at Piramal, analyses the challenges in developing and manufacturing of...

DOWNLOAD